Literature DB >> 24329192

Pharmacogenetics and individualizing drug treatment during pregnancy.

David M Haas1.   

Abstract

Pharmacogenetics as a tool to aid clinicians implement individualized pharmacotherapy is utilized in some areas of medicine. Pharmacogenetics in pregnancy is still a developing field. However, there are several areas of obstetric therapeutics where data are emerging that give glimpses into future therapeutic possibilities. These include opioid pain management, antihypertensive therapy, antidepressant medications, preterm labor tocolytics, antenatal corticosteroids and drugs for nausea and vomiting of pregnancy, to name a few. More data are needed to populate the therapeutic models and to truly determine if pharmacogenetics will aid in individualizing pharmacotherapy in pregnancy. The objective of this review is to summarize current data and highlight research needs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24329192      PMCID: PMC4064360          DOI: 10.2217/pgs.13.228

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  95 in total

1.  CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages.

Authors:  J Kirchheiner; K Brøsen; M L Dahl; L F Gram; S Kasper; I Roots; F Sjöqvist; E Spina; J Brockmöller
Journal:  Acta Psychiatr Scand       Date:  2001-09       Impact factor: 6.392

Review 2.  CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants.

Authors:  L DiAnne Bradford
Journal:  Pharmacogenomics       Date:  2002-03       Impact factor: 2.533

3.  beta2-Adrenergic receptor genotype and preterm delivery.

Authors:  Ruth Landau; Hong-Guang Xie; Victor Dishy; C Micheal Stein; Alastair J J Wood; Charles W Emala; Richard M Smiley
Journal:  Am J Obstet Gynecol       Date:  2002-11       Impact factor: 8.661

Review 4.  Prophylactic corticosteroids for preterm birth.

Authors:  P Crowley
Journal:  Cochrane Database Syst Rev       Date:  2000

5.  Psychosocial morbidity among women with nausea and vomiting of pregnancy: prevalence and association with anti-emetic therapy.

Authors:  P Mazzotta; D Stewart; G Atanackovic; G Koren; L A Magee
Journal:  J Psychosom Obstet Gynaecol       Date:  2000-09       Impact factor: 2.949

6.  Prevalence and severity of nausea and vomiting of pregnancy and effect of vitamin supplementation.

Authors:  S Emelianova; P Mazzotta; A Einarson; G Koren
Journal:  Clin Invest Med       Date:  1999-06       Impact factor: 0.825

7.  Attitudes, management and consequences of nausea and vomiting of pregnancy in the United States and Canada.

Authors:  P Mazzotta; C Maltepe; Y Navioz; L A Magee; G Koren
Journal:  Int J Gynaecol Obstet       Date:  2000-09       Impact factor: 3.561

8.  Lamotrigine clearance during pregnancy.

Authors:  T A Tran; I E Leppik; K Blesi; S T Sathanandan; R Remmel
Journal:  Neurology       Date:  2002-07-23       Impact factor: 9.910

9.  Attitudes to bioethical issues: a case study of a screening project.

Authors:  U Gustafsson Stolt; P E Liss; T Svensson; J Ludvigsson
Journal:  Soc Sci Med       Date:  2002-05       Impact factor: 4.634

10.  Association of the Gln27Glu polymorphism of the beta-2-adrenergic receptor with preterm labor.

Authors:  M Ozkur; F Dogulu; A Ozkur; B Gokmen; S S Inaloz; A S Aynacioglu
Journal:  Int J Gynaecol Obstet       Date:  2002-06       Impact factor: 3.561

View more
  6 in total

1.  Value of Genetics-informed Drug Dosing Guidance in Pregnant Women: A Needs Assessment with Obstetric Healthcare Providers at Johns Hopkins.

Authors:  Casey L Overby; Phillip Thompkins; Harold Lehmann; Christopher G Chute; Jeanne S Sheffield
Journal:  AMIA Annu Symp Proc       Date:  2018-04-16

Review 2.  The brain-placental axis: Therapeutic and pharmacological relevancy to pregnancy.

Authors:  Susanta K Behura; Pramod Dhakal; Andrew M Kelleher; Ahmed Balboula; Amanda Patterson; Thomas E Spencer
Journal:  Pharmacol Res       Date:  2019-10-07       Impact factor: 7.658

3.  Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Authors:  John V Ilekis; Ekaterini Tsilou; Susan Fisher; Vikki M Abrahams; Michael J Soares; James C Cross; Stacy Zamudio; Nicholas P Illsley; Leslie Myatt; Christine Colvis; Maged M Costantine; David M Haas; Yoel Sadovsky; Carl Weiner; Erik Rytting; Gene Bidwell
Journal:  Am J Obstet Gynecol       Date:  2016-03-10       Impact factor: 8.661

Review 4.  Precision medicine in women with epilepsy: The challenge, systematic review, and future direction.

Authors:  Yi Li; Sai Zhang; Michael P Snyder; Kimford J Meador
Journal:  Epilepsy Behav       Date:  2021-03-25       Impact factor: 2.937

Review 5.  Translational Systems Pharmacology Studies in Pregnant Women.

Authors:  Sara K Quinney; Rakesh Gullapelli; David M Haas
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-12-14

6.  Pharmacogenomic Testing In Pediatrics: Navigating The Ethical, Social, And Legal Challenges.

Authors:  Susanne B Haga
Journal:  Pharmgenomics Pers Med       Date:  2019-10-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.